13 filings
8-K
TVTX
Travere Therapeutics Inc
30 Oct 19
Retrophin Reports Third Quarter 2019 Financial Results
4:10pm
8-K
TVTX
Travere Therapeutics Inc
10 Oct 19
Departure of Directors or Certain Officers
5:16pm
8-K
TVTX
Travere Therapeutics Inc
22 Aug 19
Other Events
6:30am
8-K
TVTX
Travere Therapeutics Inc
6 Aug 19
Retrophin Reports Second Quarter 2019 Financial Results
4:12pm
8-K
TVTX
Travere Therapeutics Inc
13 May 19
Departure of Directors or Certain Officers
4:55pm
8-K
osypfz60jf4
13 May 19
Departure of Directors or Certain Officers
4:42pm
8-K
ipfzyv27gph5w8pe
13 May 19
Departure of Directors or Certain Officers
12:00am
8-K
zoc3pd16yj7u7bb2lib
7 May 19
Retrophin Reports First Quarter 2019 Financial Results
4:05pm
8-K
9znb9izqm
25 Apr 19
Entry into a Material Definitive Agreement
5:25pm
8-K
h4oz9gq25uan
19 Apr 19
Departure of Directors or Certain Officers
5:18pm
8-K
sscc g6rxl1y6g2b
26 Feb 19
Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results
4:10pm
8-K
80pk8s1ha932jwqg6omn
7 Jan 19
Retrophin Provides Corporate Update and 2019 Outlook
7:02am
8-K
9ru1mj2eeekce85ijkp
4 Jan 19
Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer
12:00am
- Prev
- 1
- Next